Stuttgart - Delayed Quote EUR
Abivax SA (2X1.SG)
5.76
-0.43
(-6.95%)
At close: June 13 at 9:56:15 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-152,596
-154,072
-97,130
-53,936
-45,048
Investing Cash Flow
14,943
15,762
-8,095
-12,026
-6,232
Financing Cash Flow
-831
28,207
335,290
32,211
82,679
End Cash Position
103,125
144,221
251,942
26,950
60,701
Capital Expenditure
-675
-643
-265
-323
-47
Issuance of Capital Stock
--
434
353,387
46,374
69,683
Issuance of Debt
23,319
47,944
55,841
0
24,913
Repayment of Debt
-14,250
-10,458
-40,602
-9,711
-5,786
Free Cash Flow
-153,271
-154,715
-97,395
-54,259
-45,095
12/31/2021 - 8/28/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade